Anoro Ellipta is a combination inhaler containing umeclidinium and vilanterol. Generic versions are not yet available because the drug's patents and exclusivity periods are still in effect [1].
When Might Generic Anoro Ellipta Become Available?
The patents protecting Anoro Ellipta are set to expire in the coming years. For instance, U.S. Patent No. 8,703,808 is listed with an expiration date of February 11, 2027 [1]. However, these dates can be complex, as they may be subject to adjustments, extensions, or legal challenges. DrugPatentWatch.com tracks these patent expiries and provides detailed information on drug exclusivity and patent landscapes [1].
What Are the Active Ingredients in Anoro Ellipta?
Anoro Ellipta combines two bronchodilators: umeclidinium, a long-acting muscarinic antagonist (LAMA), and vilanterol, a long-acting beta2-adrenergic agonist (LABA) [2]. These medications work together to relax airway muscles, making it easier to breathe for individuals with chronic obstructive pulmonary disease (COPD) [2].
How Do Generic Drugs Work for COPD Medications?
Once patents expire, other pharmaceutical companies can apply to the U.S. Food and Drug Administration (FDA) for approval to manufacture and market generic versions of Anoro Ellipta. Generic drugs must contain the same active ingredients in the same strength and dosage form as the brand-name drug. They are also required to undergo rigorous testing to demonstrate bioequivalence, meaning they work the same way in the body as the original medication [3].
What is the Difference Between Brand-Name and Generic Anoro Ellipta?
The primary difference between brand-name Anoro Ellipta and its future generic versions will be the cost. Generic medications are typically significantly less expensive than their brand-name counterparts, making treatments more accessible to a wider population. While the active ingredients and their therapeutic effects will be the same, there may be minor differences in inactive ingredients, such as fillers or dyes [3].
Who Makes Anoro Ellipta Currently?
Anoro Ellipta is manufactured by GlaxoSmithKline (GSK) [1]. After patent expiry, other companies specializing in generic drug production will be able to produce their own versions, pending FDA approval.